Efforts are underway to better characterize the patterns associated with PVs in non-BRCA1/2 breast cancer-predisposition genes in order to describe gene-specific risk factors for carrying a PV and to inform testing guidelines across all women with breast cancer or a familial cancer risk [3]. This evidence concerns the gene BRCA1 and breast carcinoma.